NDAOPHTHALMICSOLUTION/DROPSPriority Review
Approved
Dec 2017
Lifecycle
Peak
Competitive Pressure
30/100
Data completeness
3/8 — Basic
Priority Review
ALTAFLUOR BENOX (fluorescein sodium and benoxinate hydrochloride) by Engine Biosciences is 12. First approved in 2017.
Drug data last refreshed 2h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ALTAFLUOR BENOX is a fixed-dose ophthalmic solution combining fluorescein sodium (a disclosing agent) with benoxinate hydrochloride (a rapid-acting ester anesthetic). It is used for corneal anesthesia in ophthalmic procedures, with maximal anesthesia occurring within 5-45 seconds and lasting approximately 20 minutes. The product serves as an adjunct diagnostic and procedural aid in eye care.
Peak
Product is in peak commercial phase with moderate competitive pressure (30/100); team is likely focused on market penetration and maintaining share in specialist ophthalmic channels.
Mechanism of Action
12. CLINICAL PHARMACOLOGY This product is the combination of a disclosing agent with a rapidly acting ester anesthetic of short duration. 12. 2 Pharmacodynamics Maximal corneal anesthesia usually occurs in about 5-45 seconds and lasts about 20 minutes after single administration. The anesthetic…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ALTAFLUOR BENOX offers exposure to the specialized ophthalmic market with focus on provider engagement and procedure-based utilization strategies. Career growth on this product is driven by market penetration and competitive positioning rather than clinical development pipeline expansion.
Field Sales Representative
Worked on ALTAFLUOR BENOX at Engine Biosciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.